Cyted Health, a company specializing in gastrointestinal molecular diagnostics, recently announced that its US laboratory has received accreditation from the College of American Pathologists (CAP). This is a significant achievement, showcasing the lab’s commitment to high-quality standards in pathology and laboratory medicine.
Previously, the lab earned its Clinical Laboratory Improvement Amendments (CLIA) certification in January 2024. CAP accreditation builds on this foundation, confirming that the laboratory meets rigorous operational and technical standards.
Betsy Hanna, the president and US general manager at Cyted Health, stated, “Achieving CAP accreditation reflects our commitment to excellence in laboratory practice and early detection of esophageal diseases.” This accreditation is crucial, as it assures healthcare providers and patients of the lab’s reliability and precision.
The combination of CAP accreditation and CLIA certification means Cyted’s laboratory adheres to industry best practices. Such certifications are essential since they help ensure patient safety and the effectiveness of diagnostic tests.
Cyted Health is also running the DETECT-ME clinical validation study, which started enrolling patients in March 2025. This study aims to validate the performance of its innovative molecular tests for detecting esophageal conditions, particularly using a technique called EndoSign.
What sets Cyted Health apart is its approach—using minimally invasive cell collection combined with advanced molecular analysis. This method helps identify early changes linked to Barrett’s esophagus and esophageal cancer. Remarkably, they have conducted over 40,000 tests with this diagnostic platform, underscoring their commitment to advancing detection methods.
In the broader context, early detection of esophageal diseases is gaining attention. According to the American Cancer Society, esophageal cancer rates have been rising in recent years. This makes Cyted Health’s innovations particularly timely and relevant.
In summary, Cyted Health’s recent CAP accreditation highlights its dedication to quality in diagnostics. With its innovative approaches and ongoing clinical studies, the company is poised to make significant contributions to early disease detection.
Source link
Barrett\u2019s esophagus, CAP accreditation, CLIA certification, clinical laboratory, clinical validation, College of American Pathologists, Cyted Health, DETECT-ME study, EndoSign, esophageal cancer, gastrointestinal diagnostics, laboratory accreditation, laboratory quality assurance, molecular diagnostics, pathology,
